TGFB1 and neoplasm: Limiting PD-1/PD-L1 expression could be an important inhibition of TGF-β1 mediated tumor suppression mechanism, and the lack of synergistic effects of Vactosertib and ICB may be due to the loss of PD-1 or PD-L1 expression in the presence of Vactosertib.